Phase II Study of FOLFIORINOX in Older Pancreatic Cancer Patients
The purpose of this phase II trial is to evaluate the safety and tolerability of FOLFIRINOX in patients aged 65 and older with pancreatic cancer.
Study ID: GI-170
Trial Phase: Phase II
Trial Sponsor: Fox Chase Cancer Center
Therapies Used in This Trial: FOLFIRINOX